.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fuji
Dow
Chubb
Accenture
McKinsey
UBS
Baxter
Mallinckrodt
Teva

Generated: February 19, 2018

DrugPatentWatch Database Preview

Drugs with Dosage: POWDER

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
AbbvieNORISODRINEisoproterenol sulfatePOWDER;INHALATION006905-002Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;INHALATION
AbbvieNORISODRINEisoproterenol sulfatePOWDER;INHALATION006905-003Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;INHALATION
ApothekernesBACITRACINbacitracinPOWDER;FOR RX COMPOUNDING061699-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;FOR RX COMPOUNDING
Bristol MyersQUESTRANcholestyraminePOWDER;ORAL016640-001Approved Prior to Jan 1, 1982DISCNYesNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;ORAL
Bristol MyersQUESTRANcholestyraminePOWDER;ORAL016640-003Approved Prior to Jan 1, 1982DISCNYesNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;ORAL
Bristol Myers SquibbREZIPASaminosalicylic acid resin complexPOWDER;ORAL009052-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;ORAL
Century PharmsP.A.S. SODIUMaminosalicylate sodiumPOWDER;ORAL080947-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;ORAL
Concordia Pharms IncKAYEXALATEsodium polystyrene sulfonatePOWDER;ORAL, RECTAL011287-001Approved Prior to Jan 1, 1982DISCNYesNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;ORAL, RECTAL
Delcor Asset CorpMYCOSTATINnystatinPOWDER;TOPICAL060578-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;TOPICAL
HexcelPOTASSIUM AMINOSALICYLATEpotassium aminosalicylatePOWDER;ORAL080098-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpPOWDER;ORAL
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Army
Healthtrust
Citi
Cipla
Johnson and Johnson
Daiichi Sankyo
McKesson
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot